ArticleAesthetic plastic surgery2026
Psychosocial Outcomes and Aesthetic Expectations in Female Patients Undergoing Body Contouring After GLP-1-Induced Weight Loss: A Prospective Pilot Comparative Study with Post-Bariatric Patients.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe widespread adoption of glucagon-like peptide-1 (GLP-1) receptor agonists has generated a new cohort of weight loss patients seeking aesthetic surgery. Their psychosocial characteristics and aesthetic expectations, compared with traditional post-bariatric patients, remain poorly defined.
objectivesTo compare psychosocial well-being, body image, and satisfaction in female patients undergoing body contouring after GLP-1-induced versus bariatric weight loss.
methodsA single-center, prospective pilot comparative study including women only was conducted. Of 82 enrolled patients, 72 completed follow-up and were analyzed (GLP-1: n = 38; post-bariatric: n = 34). The prespecified primary endpoint was the change in BODY-Q Satisfaction with Body score from baseline (T0) to 6 months (T6). Secondary endpoints included other BODY-Q domains and, when applicable, FACE-Q and Wrinkle Severity Rating Scale (WSRS) measures. Validated patient-reported outcome measures (PROMs) were administered at T0 and T6.
resultsBoth cohorts demonstrated significant improvement in Satisfaction with Body from T0 to T6 (GLP-1: 43.1 ± 12.5 → 72.8 ± 13.9; Δ = 29.7; p < 0.001; post-bariatric: 39.6 ± 11.7 → 68.5 ± 14.7; Δ = 28.9; p < 0.001), with no between-group difference in improvement (p = 0.67). GLP-1 patients showed higher preoperative scores but greater emotional reactivity to residual contour irregularities. In the facial subgroup (n = 21), FACE-Q improved and WSRS decreased similarly across groups. Multivariable analysis revealed no independent effect of weight loss modality on BODY-Q change (β = 0.12; p = 0.58); lower baseline psychosocial scores predicted postoperative dissatisfaction (β = -0.34; p = 0.02).
conclusionsBody contouring after GLP-1-induced weight loss yields psychosocial and aesthetic benefits comparable to those achieved after bariatric surgery, yet GLP-1 patients exhibit distinct preoperative expectations and heightened emotional sensitivity to imperfections. Despite the female-only, single-center pilot design, these findings underscore the importance of tailored counseling and highlight the need for larger multicenter studies to refine patient selection and expectation management. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42310082What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.